Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2570 participants.
Also called NCT07257198
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 2,570 participants
- Sponsor
- Registry
-
NCT07257198
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Canada
- Registry status
- Recruiting
Technical summary
Registry record NCT07257198. Randomized; quadruple masking; primary purpose treatment. Start 2026-03-03 (actual); primary completion 2030-01-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone
- Acronym
- PANTHEON
- Condition
- NSTEMI - Non-ST Segment Elevation MI
- Condition
- STEMI (ST Elevation MI)
- Condition
- Myocardial Infarction
- Intervention (Drug)
- Ticagrelor + placebo
- Intervention (Drug)
- Ticagrelor + aspirin
- Lead sponsor
- Montreal Heart Institute
Record details
- Record id
cardio:ct-nct07257198- Content hash
ed44a79fd0cca5069b745be25cead328499be0ca50ca0818ab04b9e74dd6515a